Analyst price targets provided by TipRanks. Quick Links. Advanced Charting · After Hours Quote · Analyst Research 5-star analyst Soumit Roy from JonesTrading reiterated a Buy on $AGLE. tipranks.com/analysts/soumi investment & stock information. Get the latest Aeglea BioTherapeutics, Inc. AGLE detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. 25 Feb 2020 Wainwright reiterated a Buy rating on Aeglea Biotherapeutics (AGLE – Research Report), with a price target of $24.00. The company's shares
AGLE Price Target and Analyst Ratings (Aeglea Bio ...
AGLE | Aeglea BioTherapeutics Inc. Analyst Estimates ... Nov 06, 2019 · Aeglea BioTherapeutics Inc. analyst estimates by MarketWatch. View AGLE revenue estimates and earnings estimates, as well as analyst recommendations. AGLE Aeglea BioTherapeutics — Stock Price and Discussion ... Real-time trade and investing ideas on Aeglea BioTherapeutics AGLE from the largest community of traders and investors. Market Data by Xignite and BATS BZX Real-Time Price. Securities products and services offered to self-directed investors through ST Invest, LLC. AGLE: Angle Stock Price - Investing.com This is the main Angle Plc stock chart and current price. You can find more details by going to one of the sections under this page such as historical data, charts, technical analysis and others. AGLE:NASDAQ GM Stock Quote - Aeglea BioTherapeutics Inc ...
Apr 24, 2018 · Aeglea BioTherapeutics (NASDAQ:AGLE) initiated with Outperform rating and $37 (368% upside) price target at Evercore ISI. Shares up 5% premarket. Alder Bio
and margins. View AGLE financial statements in full. Fiscal Yr Ends December 31, No. of Analysts 6 Price to Book Ratio 3.70. Price to Cash Flow Ratio -. Most Recommended Stocks shows latest ranked securities in with 3 month history sorted by AGLE, 4.01, 1.00, Strong Buy, 0, 1, 1, 1, 2, 282.29 shows what Wall Street analysts think of individual stocks on US Markets like DOW, S&P 500,
Posted by Joseph McCarthy on Feb 25th, 2020 Aeglea Bio Therapeutics (NASDAQ:AGLE) had its target price hoisted by investment analysts at HC Wainwright from $20.00 to $24.00 in a report released on Tuesday, AnalystRatings.com reports. The firm currently has a “buy” rating on the biotechnology company’s stock.
Oct 27, 2019 · The high price target for AGLE is $20.00 and the low price target for AGLE is $14.00. There are currently 1 hold rating and 2 buy ratings for the stock, resulting in a consensus rating of "Buy.". Aeglea BioTherapeutics, Inc. Common Stock (AGLE) Analyst ...
Needham analyst Chad Messer maintained a Buy rating on Aeglea Biotherapeutics (AGLE – Research Report) on February 24 and set a price target of $14.00. According to TipRanks.com, Messer is a 4-star analyst with an average return of 9.2% and
In a report released today, Soumit Roy from JonesTrading reiterated a Buy rating on Aeglea Biotherapeutics Inc (AGLE – Research Report), with a price target of $16. The company’s shares closed last Monday at $7.72. Aeglea BioTherapeutics Inc. Research & Ratings (AGLE ... Feb 21, 2020 · View today's stock price, news and analysis for Aeglea BioTherapeutics Inc. (AGLE). Barron's also provides information on historical stock ratings, target prices, company earnings, market NVIDIA Stock May Hit Record High on Profit Growth Jul 09, 2018 · According to data from YCharts, the highest price target on the stock is currently $340, nearly 35% higher than its current price around $246 a share. NVDA Price Target High data by YCharts. Aeglea BioTherapeutics Inc - AGLE - Stock price forecast AGLE stock forecast Our latest prediction for Aeglea Biotherapeutics, Inc.'s stock price was made on the June 14, 2019 when the stock price was at 6.18$. In the short term (2weeks), AGLE's stock price should outperform the market by 3.46%. During that period the price should oscillate between …